Ponuka pracovných pozícií
Zistite viac o príležitostiach v spoločnosti Novartis. Pre ďalšie pracovné ponuky v Novartis Gene Therapies (predtým AveXis) navštívte GTx Career Search .
Oznámenie pre uchádzačov o voľné pracovné miesta v USA. Zistite viac
Showing 549 results
- Sort by Sort ascending
- Názov pracovnej pozície Sort ascending
- Oblasť pôsobenia
- Miesto výkonu práce
- Stránka
- Dátum pridania
| Názov pracovnej pozície Sort ascending | Oblasť pôsobenia | Miesto výkonu práce | Stránka | Dátum pridania |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Salt Lake City Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - South Florida Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Virginia - Carolinas Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Dec 02, 2025 |
| Direktor terapevtskih področij (m/ž/d) / Therapeutic Area Head (m/f/d) Regular, Full time | Marketing | Slovenia | Ljubljana | Dec 02, 2025 |
| Head, Public Affairs, Denmark Regular, Full time | Audit & Compliance | Denmark | Copenhagen | Dec 02, 2025 |
| Time Services Expert - 3 Temporary positions - 12 months Regular, Full time | Human Resources | Mexico | INSURGENTES | Dec 02, 2025 |
| Developer (R), Tech & Scientific Computing Regular, Full time | Development | Ireland +Alternative Locations | Dublin (NOCC) | Dec 02, 2025 |
| AI Engineer Engineer DD&IT US&I Regular, Full time | Information Technology | Mexico | INSURGENTES | Dec 02, 2025 |
| Associate Director, DDIT M&A Deal Enablement,Technical Business Analyst Regular, Full time | Information Technology | Czech Republic | Prague | Dec 02, 2025 |
| Commercial Alliances Associate Regular, Full time | General Management | Australia | New South Wales (NSW) | Dec 02, 2025 |